Middle East and Africa Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Oct 2019
  • MEA
  • 350 Pages
  • No of Tables: 75
  • No of Figures: 42

Middle East and Africa Clinical Trial Imaging Market By Product & Services (Services, Software), Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Others), Application (Oncology, Neurology, Endocrinology, Cardiology, Dermatology, Hematology, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic and Government Research Institutes, Medical Device Manufacturers, Others), Distribution Channel (Direct Sales, Tender Sales), Country (South Africa, South Arabia, Rest of Middle East & Africa) – Industry Trends and Forecast to 2026

Imaging techniques are highly used in oncological clinical trials for gaining accurate evidences in order to make a good decision. In the clinical trial imaging, the technology of imaging representations for medical includes the service of radiographers (X-ray technologists), medical physicists, radiologists, sonographers (ultrasound technologists), nurses and biomedical engineers.

The first computer-based image analysis was introduced in the year 1960. Initially medical imaging was started with the technology of X-rays, at that time the procedure of X-ray would be passed through the body onto some film, which would generate an image and it would take around 11 minutes to complete the procedure of X-ray. Digitalization technique was introduced in 1970. This new technique contains digital image of the inner parts of the body such as computed tomography scanner. This digital technique has many benefits such as ease of storing records, it has the ability to use computers to analyze images and detect issues and it has the ability to enhance images with the use of technology.

Middle East and Africa clinical trial imaging market is projected to register a substantial CAGR in the forecast period 2019 to 2026.

Segmentation: Middle East and Africa Clinical Trial Imaging Market

Middle East and Africa clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and of distribution channel.

  • On the basis of product & services, the market is segmented into services and software
  • On the basis of Modality, the market is segmented into computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, x-ray, ultrasound, optical coherence tomography and others
  • On the basis of application, the market is segmented into oncology, neurology, endocrinology, cardiology, dermatology, hematology and others
  • On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic and government research institutes, medical device manufacturers  and others
  • On the basis of distribution channel, the market is segmented into direct sales and tender sales

Competitive Analysis: Middle East and Africa Clinical Trial Imaging Market

Some of the major players operating in this market are BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC, Lyscaut Medical Imaging Company, Quotient Sciences, worldcare Clinical, Navitas Life Sciences, Cardiovascular Imaging Technologies, Intrinsic Imaging, Image Core Lab, ERT Clinical, Perspectum Diagnostics, Anagram 4 clinical trials, Parexel International Corporation among others.

 Recent Developments

  • In May 2019, ICON Plc announced that they have acquired MeDiNova Research. After this acquisition the company has enhanced their patient recruitment capabilities in EMEA and complements ICON existing site network in the U.S., PMG Research
  • In February 2019, ICON Plc announced that they have acquired MolecularMD, a molecular diagnostic specialty laboratory. After this acquisition ICON’s laboratory has enhanced its offerings in molecular diagnostic testing leading towards the expansion of testing platforms, such as next immunohistochemistry (IHC) and generation sequencing

Research Methodology: Middle East and Africa Clinical Trial Imaging Market ​​​​​​​

Primary Respondents:

Key Opinion Leaders (KOL’s): Doctors, Healthcare Professionals, Researchers, Distributors, and Industrialists

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 COST OF CLINICAL TRIAL PHASE 2 AND PHASE 3

TABLE 2 HUGE R&D COST IN THE U.S. FOR DIFFERENT PHASES

TABLE 3 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES, 2017-2026 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA SOFTWARE CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 8 ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA NEUROLOGYI N CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA ENDOCRINOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA CARDIOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA DERMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA HEMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA COMPUTED TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA MAGNETIC RESONANCE IMAGING IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ULTRASOUND IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA POSITRON EMISSION TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA X-RAY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA ECHOCARDIOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA OPTICAL COHERENCE TOMOGRAPHYIN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA OTHERS SEGMENTS IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA MEDICAL DEVICE MANUFACTURERS COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN CLINICAL TRIAL IMAGINGMARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA DIRECT SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA TENDERS SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION,2017-2026 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 51 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 52 SAUDI ARABIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 53 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 54 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 SAUDI ARABIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 SAUDI ARABIA NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 57 SAUDI ARABIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 58 SAUDI ARABIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 SAUDI ARABIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 SAUDI ARABIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 63 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 SOUTH AFRICA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 66 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 SOUTH AFRICA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 SOUTH AFRICA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 SOUTH AFRICA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 SOUTH AFRICA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 71 SOUTH AFRICA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 72 SOUTH AFRICA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 75 REST OF MEA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19